Myxoma left ventricle in a patient with human immunodeficiency syndrome
Abstract
Background: cardiovascular complications are frequent at final stages of acquired immunodeficiency syndrome. At these points, cardiac tumors can be seen with low frequency.
Objective: to present the case of a patient with cardiac insufficiency signs and preceding four-year acquired immunodeficiency syndrome.
Clinical case: a thirty-year-old black female patient, who received four-year antiretroviral therapy for acquired immunodeficiency syndrome. She began having palpitations, edemas of inferior limbs, noticeable asthenia, and low intensity dyspnea, which was increasing later. Because of this symptomatology, the patient goes to casualty department.
Conclusions: echocardiography is a valuable tool when diagnosing the presence of cardiac tumors in a fast and simple way. Patients who suffer from acquired immunodeficiency syndrome and have cardiac decompensation signs are exposed to these types of tumors. A definitive diagnosis in this patient was made after her death (post-mortem), because she died due to other clinical complications.
DeCS: MYXOMA; ACQUIRED IMMUNODEFICIENCY SYNDROME; HEART FAILURE; ADULT; CASE REPORTS.
Downloads

Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/